Understanding the Demand for Illegal Drugs

Understanding the Demand for Illegal Drugs

Volumn , Issue , 2010, Pages 1-113

  Reuter, Peter ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84983652949     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.17226/12976     Document Type: Book

References (258)

1. Arseneault, L., M. Cannon, J. Witten, and R. Murray. (2004). Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry, 184 , 110-117.
2. Babor, T., J. Caulkins, G. Edwards, D. Foxcroft, K. Humphreys, M.M. Mora, I. Obot, J. Rehm, P. Reuter, R. Room, I. Rossow, and J. Strang. (2010). Drug Policy and the Public Good. New York: Oxford University Press.
3. Carnevale, J. (2009). Restoring the Integrity of the Office of National Drug Control Policy. Testimony at the hearing on the Office of National Drug Control Policy's Fiscal Year 2010 National Drug Control Budget and the Policy Priorities of the Office of National Drug Control Policy Under the New Administration. The Domestic Policy Subcommittee of the House Committee on Oversight and Government Reform. May 19, 2009. Available: http://carnevaleassociates.com/Testimony%20of%20John%20Carnevale%20May%2019%20-%20FINAL.pdf [accessed August 2010].
4. Caulkins, J., and R. Mennefee. (2009). Is objective risk all that matters when it comes to drugs? Journal of Drug Policy Analysis, 2(1), Art. 1. Available: http://www.bepress.com/jdpa/vol2/iss1/art1/ [accessed August 2010].
5. District of Columbia Pretrial Services Agency. (2009). PSA's Electronic Reading Room-FOIA.Available: http://www.dcpsa.gov/foia/foiaERRpsa.htm [accessed May 2009].
6. European Monitoring Center for Drugs and Drug Addiction. (2007). 2007 Annual Report: The State of the Drug Problem in Europe. Lisbon, Portugal. Available: http://www.emcdda.europa.eu/publications/annual-report/2007 [accessed May 2009].
7. Fergusson, D.M., J.M. Boden, and L.J. Horwood. (2006). Cannabis use and other illicit drug use: Testing the cannabis gateway hypothesis. Addiction, 6(101), 556-569.
8. Gallup Poll. (2009). Illegal Drugs. Available: http://www.gallup.com/poll/1657/illegaldrugs.aspx [accessed April 2010].
9. Golub, A., and B. Johnson. (2001). Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. American Journal of Public Health, 91 (2), 225-232.
10. Iversen, L. (2005). Long-term effects of exposure to cannabis. Current Opinion in Pharmacology, 5(1), 69-72. Available: http://www.safeaccessnow.org/downloads/long%20term %20cannabis%20effects.pdf [accessed July 2010].
11. National Institute of Justice. (2003). Preliminary Data on Drug Use & Related Matters Among Adult Arrestees & Juvenile Detainees 2002. Washington, DC: U.S. Department of Justice.
12. National Institute on Drug Abuse. (2010). NIDA InfoFacts: Heroin. Available: http://www.drugabuse.gov/infofacts/heroin.html [accessed August 2010].
13. National Research Council. (2001). Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us. Committee on Data and Research for Policy on Illegal Drugs, C.F. Manski, J.V. Pepper, and C.V. Petrie (Eds.). Committee on Law and Justice and Committee on National Statistics. Commission on Behavioral and Social Sciences and Education. Washington, DC: National Academy Press.
14. Office of National Drug Control Policy. (1993). State and Local Spending on Drug Control Activities. NCJ publication no. 146138. Washington, DC: Executive Office of the President.
15. Office of National Drug Control Policy. (2001). What America's Users Spend on Illegal Drugs 1988-2000. W. Rhodes, M. Layne, A.-M. Bruen, P. Johnston, and L. Bechetti. Washington, DC: Executive Office of the President.
16. Pollack, H., P. Reuter., and P. Sevigny. (2010). If Drug Treatment Works So Well, Why Are So Many Drug Users in Prison? Paper presented at the meeting of the National Bureau of Economic Research on Making Crime Control Pay: Cost-Effective Alternatives to Incarceration, July, Berkeley, CA. Available: http://www.nber.org/chapters/c12098.pdf [accessed August 2010].
17. Trunzo, D., and L. Henderson. (2007). Older Adult Admissions to Substance Abuse Treatment: Findings from the Treatment Episode Data Set. Paper presented at the meeting of the American Public Health Association, November 6, Washington, DC. Available: http://apha.confex.com/apha/135am/techprogram/paper_160959.htm [accessed August 2010].
18. Walsh, J. (2009). Lowering Expectations: Supply Control and the Resilient Cocaine Market. Available: http://www.eluniversal.com.mx/graficos/pdf09/wolareportcocaine.pdf [accessed August 2010].
19. Wills, T., C. Walker, and J. Resko. (2005). Longitudinal studies of drug use and abuse. In Z. Slobada (Ed.), Epidemiology of Drug Abuse (pp. 177-192). New York: Springer.
20. Akerlof, G. (1970). The market for "lemons": Quality uncertainty and the market mechanism. Quarterly Journal of Economics, 84 (3), 488-500.
21. Akerlof, G.A., and L.J. Yellen. (1986). Efficiency Wage Models of the Labor Market. Cambridge, UK: Cambridge University Press.
22. Auld, M.C., and P. Grootendorst. (2004). An empirical analysis of milk addiction. Journal of Health Economics, 23 (6), 1,117-1,133.
23. Becker, G. (1968). Crime and punishment: An economic approach. Journal of Political Economy, 76(2), 169-217.
24. Becker, G.S., and K.M. Murphy. (1988). A theory of rational addiction. Journal of Political Economy, 96, 675-700.
25. Becker, G.S., M. Grossman, and K.M. Murphy. (1994). An empirical model of cigarette addiction. American Economic Review, 84 (3), 396-418.
26. Becker, G.S., K.M. Murphy, and M. Grossman. (2006). The market for illegal goods: The case of drugs. Journal of Political Economy, 114 (1), 38-60.
27. Bernheim, B.D., and A. Rangel. (2004). Addiction and cue-triggered decision processes. American Economic Review, 94 (5), 1,558-1,590.
28. Bourgois, P. (1996). In Search of Respect: Selling Crack in El Barrio. New York: Cambridge University Press.
29. Caulkins, J. (2001). Drug prices and emergency department mentions for cocaine and heroin. American Journal of Public Health, 91 (9), 1,446-1,448.
30. Caulkins, J. (2007). Price and purity analysis for illicit drug: data and conceptual issues. Drug and Alcohol Dependence, 90(Supplement), S61-S68.
31. Caulkins, J.P., and R.L. Pacula. (2006). Marijuana markets: Inferences from reports by the household population. Journal of Drug Issues, 36(1), 173-200.
32. Caulkins, J.P., and P. Reuter. (1998).What price data tell us about drug markets. Journal of Drug Issues, 28 (3), 593-612.
33. Chaloupka, F. (1991). Rational addictive behavior and cigarette smoking. Journal of Political Economy, 99 (4), 722-742.
34. Chaloupka, F.J., K.M. Cummings, C.P. Morley, and J.K. Horan. (2002). Tax, price and cigarette smoking: Evidence from the tobacco documents and implications for tobacco company marketing strategies. Tobacco Control, 11 , I62-I72.
35. Cook, P.J., and M.J. Moore. (1993). Drinking and schooling. Journal of Health Economics, 12 (4), 411-430.
36. Curtis, R., and T. Wendel. (2000). Toward the development of a typology of illegal drug markets. Crime Prevention Studies, 11 , 121-152.
37. Dave, D. (2004). Illicit Drug Use Among Arrestees and Drug Prices. Cambridge, MA: National Bureau of Economic Research.
38. Dave, D. (2006). The effects of cocaine and heroin price on drug-related emergency department visits. Journal of Health Economics, 25 (2), 311-333.
39. Easterlin, R. (1978). What will 1984 be like? Socioeconomic implications of recent twists in age structure. Demography, XV, 397-421.
40. Frank, R.H., and B.S. Bernanke. (2004). Principles of Microeconomics, 2nd edition. New York: McGraw-Hill.
41. Fuentes, J.R. (1998). Life of a Cell: Managerial Practice and Strategy in Colombian Cocaine Distribution in the United States. PhD dissertation. New York: City University of New York.
42. Galenianos, M., N. Persico, and R. Pacula. (2009). A Search-Theoretic Model for the Retail Market for Illicit Drugs. NBER Working Paper 14980. Cambridge, MA: National Bureau of Economic Research.
43. Goldstein, P., H. Brownstein, and P. Ryan. (1992). Drug-related homicide in New York: 1984 and 1988. Crime and Delinquency, 38 (4), 459-476.
44. Grossman, M. (2004). Individual Behaviors and Substance Use: The Role of Price. NBER Working Paper. Cambridge, MA: National Bureau of Economic Research.
45. Grossman, M., F.J. Chaloupka, and K. Shim. (2002). Illegal drug use and public policy. Health Affairs, 21 (2), 134-145.
46. Gruber, J., and B. Koszegi. (2001). Is addiction "rational"? Theory and evidence. Quarterly Journal of Economics, 116(4), 1,261-1,303.
47. Hagedorn, J. (1998). The business of drug dealing in Milwaukee. Wisconsin Policy Research Institute, 11 (5).
48. Jacobson, M. (2004). Baby booms and drug busts: trends in youth drug use in the United States, 1975-2000. Quarterly Journal of Economics, 119 (4), 1,481-1,512.
49. Johnson, B., P. Goldstein, E. Preble, J. Schmeidler, D. Lipton, B. Spunt, and T. Miller. (1985). Taking Care of Business: The Economics of Crime by Heroin Abusers. Lexington, MA: D.C. Heath.
50. Johnson, B., A. Golub, and E. Dunlap. (2000). The rise and decline of hard drugs, drug markets, and violence in inner-city New York. In A. Blumstein and J. Wallmen (Eds.), The Crime Drop in America (pp. 164-206). New York: Cambridge University Press.
51. Kilmer, B., and P. Reuter. (2009). Prime numbers: Doped. Foreign Policy, November/December, 34-35. Available: http://www.foreignpolicy.com/articles/2009/10/19/prime_numbers_doped [accessed August 2010].
52. Kuziemko, I., and S.D. Levitt. (2004). An empirical analysis of imprisoning drug offenders. Journal of Public Economics, 88 (9-10), 2,043-2,066.
53. Levitt, S.D., and S.A. Venkatesh. (2000). An economic analysis of a drug-selling gang's finances. Quarterly Journal of Economics, 115 (3), 755-789.
54. Luksetich, W., and M. White. (1983). Heroin: Price elasticity and enforcement strategies. Economic Inquiry, 21 , 557-564.
55. National Drug Intelligence Center. (2007a). Chicago High Intensity Drug Trafficking Area Drug Market Analysis. Available: http://www.justice.gov/ndic/pubs23/23482/23482p.pdf [accessed July 2010]
56. National Drug Intelligence Center. (2007b). Los Angeles High Intensity Drug Trafficking Area Drug Market Analysis. Available: http://www.justice.gov/ndic/pubs23/23937/distro.htm [accessed July 2010].
57. National Institute of Justice. (2003). 2000 Arrestee Drug Abuse Monitoring: Annual Report.Washington, DC: U.S. Department of Justice.
58. National Research Council. (2001). Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us. Committee on Data and Research for Policy on Illegal Drugs, C.F. Manski, J.V. Pepper, and C.V. Petrie (Eds.). Committee on Law and Justice and Committee on National Statistics, Commission on Behavioral and Social Sciences and Education. Washington, DC: National Academy Press.
59. Office of National Drug Control Policy. (2001). What America's Users Spend on Illegal Drugs: 1988-2000. Washington, DC: Executive Office of the President.
60. Office of National Drug Control Policy. (2004). The Price and Purity of Illicit Drugs: 1981 Through the Second Quarter of 2003. Washington, DC: Executive Office of the President.
61. Orphanides, A., and D. Zervos. (1995). Rational addiction with learning and regret. Journal of Political Economy, 103(4), 739-758.
62. Pacula, R.L., M. Grossman, F.J. Chalupka, P.M. O'Malley, L.D. Johnston, and M.C. Farrelly. (2001). Marijuana and youth. In J. Guber (Ed.), Risky Behavior Among Youths: An Economic Analysis (pp. 271-326). Chicago, IL: University of Chicago Press.
63. Pacula, R.L., B. Kilmer, M. Grossman, and F. Chaloupka. (2010). Risks and prices: The role of user sanctions in marijuana markets. The B.E. Journal of Economic Analysis and Policy, 10(1), Art. 11.
64. Preble, E., and J.J. Casey. (1969). Taking care of business-The heroin user's life on the street. Substance Use and Misuse, 4(1), 1-24.
65. Reuter, P., and J.P. Caulkins. (2004). Illegal "lemons": Price dispersion in cocaine and heroin markets. Bulletin on Narcotics, 56, 141-165.
66. Reuter, P., R. MacCoun, and P. Murphy. (1990). Money from Crime: A Study of the Economics of Drug Dealing in Washington, DC. Santa Monica, CA: RAND.
67. Rhodes, W., P. Johnston, S. Han, Q. McMullen, and L. Hozik. (2002). Illicit Drugs: Price Elasticity of Demand and Supply. Cambridge, MA: Abt Associates.
68. Rhodes, W., D. Hunt, M. Chapman, R. Kling, D. Fuller, and C. Dvous. (2007). Using ADAM Data to Investigate the Effectiveness of Drug Enforcement. Cambridge, MA: Abt Associates.
69. Walsh, J. (2008). U.S. Drug Policy: At What Cost? Moving Beyond the Self-Defeating Supply Control Fixation. Statement before the Joint Economic Committee of the U.S. Congress, June 19.
70. Zinberg, N. (1984). Drug, Set, and Setting: The Basis for Controlled Intoxicant Use. New Haven, CT: Yale University Press.
71. Abe-Kim, J., D.T. Takeuchi, S. Hong, N. Zane, S. Sue, M.S. Spencer, H. Appel, E. Nicdao, and M. Alegria. (2007). Use of mental health-related services among immigrant and U.S.-born Asian Americans: Results from the National Latino and Asian American study. American Journal of Public Health, 97 (1), 91-98.
72. Agar, M., and H.S. Reisinger. (2002). A heroin epidemic at the intersection of histories: The 1960s epidemic among African Americans in Baltimore. Medical Anthropology, 21 , 189-230.
73. Alegria, M., J.S. Jackson, R.C. Kessler, and D. Takeuchi. (No date). Codebook for National Comorbidity Survey Replication (NCS-R) 2001-2003. Ann Arbor, MI: Inter-university Consortium for Political and Social Research.
74. Alegria, M., N. Mulvaney-Day, M. Woo, M. Torres, S. Gao, and V. Oddo. (2007). Correlates of past-year mental health service use among Latinos: Results from the National Latino and Asian American Study. American Journal of Public Health, 97 (1), 76-83.
75. Arkes, J., R.L. Pacula, S.M. Paddock, J.P. Caulkins, and P. Reuter. (2008). Why the DEA STRIDE Data Are Still Useful for Understanding Drug Markets. Cambridge, MA: National Bureau of Economic Research.
76. Bachman, J.G., L.D. Johnston, and P.M. O'Malley. (2001). The Monitoring the Future project after twenty-seven years: Design and procedures. In Monitoring the Future Occasional Papers. Ann Arbor, MI: Institute for Social Research.
77. Basu, A., A.D. Paltiel, and H.A. Pollack. (2008). Social costs of robbery and the cost-effectiveness of substance abuse treatment. Health Economics, 17 (8), 927-946.
78. Bretteville-Jensen, A.L. (2006). Drug demand-Initiation, continuation and quitting. The Economist, 154 (4), 491-516.
79. Caulkins, J.P. (2007). Price and purity analysis for illicit drug: Data and conceptual issues. Drug Alcohol Dependence, 90(S1), S61-S68.
80. Caulkins, J.P., D.A. Behrens, C. Knoll, G. Tragler, and D. Zuba. (2004). Markov chain modeling of initiation and demand: The case of the U.S. cocaine epidemic. Health Care Management Science, 7(4), 319-329.
81. Chae, D.H., A.R. Gavin, and D.T. Takeuchi. (2006). Smoking prevalence among Asian Americans: Findings from the National Latino and Asian American study (NLAAS). Public Health Reports, 121 (6), 755-763.
82. Chatterji, P., M. Alegria, M. Lu, and D. Takeuchi. (2007). Psychiatric disorders and labor market outcomes: Evidence from the National Latino and Asian American study. Health Economics, 16(10), 1,069-1,090.
83. Child Trends Data Bank. (2010). High School Dropout Rates. Available: http://www.childtrends databank.org/?q=node/162 [accessed August 2010].
84. Community Epidemiology Work Group. (2009). Epidemiologic Trends in Drug Abuse: Proceedings of the Community Epidemiology Work Group. Available: http://www.drugabuse.gov/PDF/CEWG/CEWGJan09508Compliant.pdf [accesssed August 2010].
85. Compton, W.M., and N.D. Volkow. (2006). Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence, 81 (2), 103-107.
86. Cork, D. (1999). Examining space-time interaction in city-level homicide data: Crack markets and the diffusion of guns among youth. Journal of Quantitative Criminology, 15 (4), 379-406.
87. De Angelis, D., M. Hickman, and S. Yang. (2004). Estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use and the number of former users: Back-calculation methods and opiate overdose deaths. American Journal of Epidemiology, 160(10), 994-1,004.
88. Degenhardt, L., W.T. Chiu, N. Sampson, R.C. Kessler, and J.C. Anthony. (2007). Epidemiological patterns of extra-medical drug use in the United States: Evidence from the National Comorbidity Survey Replication, 2001-2003. Drug Alcohol Dependence, 90(2-3), 210-223.
89. District of Columbia Pretrial Services Agency. (2009). Drug Testing Statistics. Available: http://www.dcpsa.gov/foia/foiaERRpsaDT.htm#Juv [accessed May 2009].
90. Fendrich, M., T.P. Johnson, J.S. Wislar, A. Hubbell, and V. Spiehlter. (2004). The utility of drug testing in epidemiological research: Results from a general population survey. Addiction, 99 (2), 197-208.
91. Flynn, P.M., D.D. Simpson, M.D. Anglin, and R.L. Hubbard. (2001). Comment on nonresponse and selection bias in treatment follow-up studies. Substance Use and Misuse, 36(12), 1,753-1,757.
92. Ford, B.C., K.M. Bullard, R.J. Taylor, A.K. Toler, H.W. Neighbors, and J.S. Jackson. (2007). Lifetime and 12-month prevalence of diagnostic and statistical manual of mental disorders, fourth edition disorders among older African Americans: Findings from the national survey of American life. American Journal of Geriatric Psychiatry, 15 (8), 652-659.
93. Fryer, R.G., P.S. Heaton, S.D. Levitt, and K.M. Murphy. (2005). Measuring the Impact of Crack Cocaine. NBER Working Paper 11318. Cambridge, MA: National Bureau of Economic Research.
94. Galea, S., and M. Tracy. (2007). Participation rates in epidemiologic studies. Annals of Epidemiology, 17 (9), 643-653.
95. Gerstein, D.R., and R.A. Johnson. (2000). Nonresponse and selection bias in treatment follow-up studies. Substance Use and Misuse, 35 (6-8), 971-1,014.
96. Gerstein, D.R., and R.A. Johnson. (2001). In reply to Patrick M. Flynn and colleagues. Substance Use and Misuse, 36(12), 1,753-1,757.
97. Gerstein, D.R., A.R. Datta, J.S. Ingels, R.A. Johnson, K.A. Rasinski, S. Schildhaus, and K. Talley. (1997). National Treatment Improvement Evaluation Study (NTIES) Final Report. Chicago: National Opinion Research Center at the University of Chicago. Available: http://www.icpsr.umich.edu/SAMHDA/NTIES/NTIES-PDF/ntiesfnl.pdf [accessed February 2010].
98. Gfroerer, J. (1992). An overview of the National Household Survey on Drug Abuse and related methodological research. In Proceedings of the Section on Survey Research Methods (pp. 464-469). Alexandria, VA: American Statistical Association.
99. Gfroerer, J., D. Wright, and A. Kopstein. (1997). Prevalence of youth substance use: The impact of methodological differences between two national surveys. Drug and Alcohol Dependence, 47 (1), 19-30.
100. Hamid, A. (1991). Ganja to crack: Caribbean participation in the underground economy in Brooklyn, 1976-1986. Part 1, Establishment of the marijuana economy. International Journal of the Addictions, 26(6), 615-628.
101. Harrison, L.D. (1995). The validity of self-reported data on drug use. Journal of Drug Issues, 25 (1), 91-111.
102. Harrison, L.D., and A. Hughes (Eds.). (1997). The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates. NIDA Research Monograph 167. NIH Pub. No. 97-4141. Washington, DC: U.S. Government Printing Office. Available: http://www.nida.nih.gov/pdf/monographs/monograph167/download167.html [accessed August 2010].
103. Harrison, L.D., S.S. Martin, T. Enev, and D. Harrington. (2007). Comparing Drug Testing and Self-Report of Drug Use Among Youths and Young Adults in the General Population. HHS Publication No. SMA 07-4249, Methodology Series M-7. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Available: http://www.oas.samhsa.gov/validity/drugTest.cfm [accessed August 2010].
104. Heeringa, S.G., J. Wagner, M. Torres, N. Duan, T. Adams, and P. Berglund. (2004). Sample designs and sampling methods for the Collaborative Psychiatric Epidemiology Studies (CPES). International Journal of Methods of Psychiatric Research, 13 (4), 221-240.
105. Hoffer, L. (2006). Junkie Business: The Evolution and Operation of a Heroin Dealing Network.Belmont, CA: Thompson Wadsworth.
106. Horowitz, J.L. (2001). Should the DEA's STRIDE data be used for economic analyses of markets for illegal drugs? Journal of the American Statistical Association, 96(456), 1,254-1,262.
107. Hser, Y.I., V. Hoffman, C.E. Grella, and M.D. Anglin. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58 (5), 503-508.
108. Jackson, J.S., M. Torres, C.H. Caldwell, H.W. Neighbors, R.M. Nesse, R.J. Taylor, S.J. Trierweiler, and D.R. Williams. (2004a). The National Survey of American Life: A study of racial, ethnic and cultural influences on mental disorders and mental health. International Journal of Methods in Psychiatric Research, 13 (4), 196-207.
109. Jackson, J.S., H.W. Neighbors, R.M. Nesse, S.J. Trierweiler, and M. Torres. (2004b). Methodological innovations in the National Survey of American Life. International Journal of Methods of Psychiatric Research, 13 (4), 289-298.
110. Jackson, J.S., H.W. Neighbors, M. Torres, L.A. Martin, D.R. Williams, and R. Baser. (2007). Use of mental health services and subjective satisfaction with treatment among Black Caribbean immigrants: Results from the National Survey of American Life. American Journal of Public Health, 97 (1), 60-67.
111. Jacob, B., and J. Ludwig. (2006). The Effect of Family Income on Youth Outcomes: New Evidence from a Housing Voucher Lottery. NBER Working Paper 14570. Cambridge, MA: National Bureau of Economic Research.
112. Johnston, L.D., P.M. O'Malley, J.G. Bachman, and J.E. Schulenberg. (2009). Trends in Annual Prevalence of an Illicit Drug Use Index in Grades 8, 10, and 12. Institute for Social Research 2009 [cited January 31, 2010]. Available: http://www.monitoringthefuture.org/data/09data.html [accessed August 2010].
113. Kilmer, B., and R.L. Pacula. (2009). Estimating the Size of the Global Drug Market: A Demand-Side Approach. Report 2. Santa Monica, CA: RAND.
114. Kozel, N.J., and E.H. Adams. (1986). Epidemiology of drug abuse: An overview. Science, 234, 970-974.
115. Law, M.G., M. Lynskey, J. Ross, and W. Hall. (2001). Back-projection estimates of the number of dependent heroin users in Australia. Addiction, 96(3), 433-443.
116. Levitt, S. (2004). Understanding why crime fell in the 1990s: Four factors that explain the decline and six that do not. Journal of Economic Perspectives, 18 (1), 163-190.
117. Levitt, S.D., and S.A. Venkatesh. (2000). An economic analysis of a drug-selling gang's finances. Quarterly Journal of Economics, 115 (3), 755-789.
118. MacCoun, R.J., and P. Reuter. (2001). Drug War Heresies: Learning from Other Vices, Times, and Places. New York: Cambridge University Press.
119. Midanik, L. (1982). The validity of self-reported alcohol consumption and alcohol problems: Literature review. British Journal of Addiction, 77 (4), 357-382.
120. Midanik, L.T., and T.K. Greenfield. (2003). Telephone versus in-person interviews for alcohol use: Results of the 2000 National Alcohol Survey. Drug and Alcohol Dependence, 72 (3), 209-214.
121. Minkoff, H., T. Bauer, and T. Joyce. (1997). Welfare reform and the obstetrical care of immigrants and their newborns. New England Journal of Medicine, 337 (10), 705-707.
122. Murphy, S., P. Sales, M. Duterte, and C. Jacinto. (2005). A Qualitative Study of Ecstasy Sellers in the San Francisco Bay Area. A research report submitted to the U.S. Department of Justice. Available: http://www.ncjrs.gov/pdffiles1/nij/grants/209267.pdf [accessed August 2010].
123. National Drug Intelligence Center. (2008). National Drug Threat Assessment 2009: Marijuana.Washington, DC: U.S. Department of Justice. Available: http://www.justice.gov/ndic/pubs31/31379/marijuan.htm [accessed August 2010].
124. National Institute on Drug Abuse. (1997). The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates. Research Monograph 167. Washington, DC: National Institute on Drug Abuse.
125. National Institute on Drug Abuse. (2010). Community Epidemiology Work Group (CEWG). Available: http://www.drugabuse.gov/about/organization/CEWG/CEWGHome.html [accessed August 2010].
126. National Research Council. (2001). Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us. Committee on Data and Research for Policy on Illegal Drugs, C.F. Manski, J.V. Pepper, and C.V. Petrie (Eds.). Committee on Law and Justice and Committee on National Statistics, Commission on Behavioral and Social Sciences and Education. Washington, DC: National Academy Press.
127. Neighbors, H.W., C. Caldwell, D.R. Williams, R. Nesse, R.J. Taylor, K.M. Bullard, M. Torres, and J.S. Jackson. (2007). Race, ethnicity, and the use of services for mental disorders: Results from the National Survey of American Life. Archives of General Psychiatry, 64(4), 485-494.
128. Nicdao, E.G., S. Hong, and D.T. Takeuchi. (2007). Prevalence and correlates of eating disorders among Asian Americans: Results from the National Latino and Asian American Study. International Journal of Eating Disorders, 40, S22-S26.
129. Nordt, C., and R. Stohler. (2006). Incidence of heroin use in Zurich, Switzerland: A treatment case register analysis. Lancet, 367, 1,830-1,834.
130. Office of National Drug Control Policy. (1995). What America's Users Spend on Illegal Drugs, 1988-1993. Washington, DC: Executive Office of the President.
131. Office of National Drug Control Policy. (1997). What America's Users Spend on Illegal Drugs, 1988-1995. Washington, DC: Executive Office of the President.
132. Office of National Drug Control Policy. (2001). What America's Users Spend on Illegal Drugs, 1988-2000. Washington, DC: Executive Office of the President.
133. Office of National Drug Control Policy. (2008). The Price and Purity of Illicit Drugs: 1981-2007. Washington, DC: Executive Office of the President.
134. Office of National Drug Control Policy. (2009). Arrestee Drug Abuse Monitoring (ADAM) II 2008 Annual Report. Washington, DC: Executive Office of the President.
135. Paoli, L., V.A. Greenfield, and P. Reuter. (2009). The World Heroin Market: Can Supply Be Cut?New York: Oxford University Press.
136. Pennell, B.E., A. Bowers, D. Carr, S. Chardoul, G.Q. Cheung, K. Dinkelmann, N. Gebler, S.E. Hansen, S. Pennell, and M. Torres. (2004). The development and implementation of the National Comorbidity Survey Replication, the National Survey of American Life, and the National Latino and Asian American Survey. International Journal of Methods of Psychiatric Research, 13 (4), 241-269.
137. Pollack, H.A., and P. Reuter. (2006). Welfare receipt and substance-abuse treatment among low-income mothers: The impact of welfare reform. American Journal of Public Health, 96(11), 2,024-2,031.
138. Pollack, H.A., P. Reuter, and E. Sevigny. (2010). If Drug Treatment Works So Well, Why Are So Many Drug Users in Prison? Cambridge, MA: National Bureau of Economic Research.
139. Rhodes, W., and R. Kling. (2001). Should the DEA's STRIDE data be used for economic analyses of markets for illegal drugs? Comment. Journal of the American Statistical Association, 96(456), 1,264-1,266.
140. Rocheleau, A.M., and D. Boyum. (1994). Heroin Uses in New York, Chicago, and San Diego.Washington, DC: U.S. Government, Office of National Drug Control Policy.
141. Rydell, C.P., and S.S. Everingham. (1994). Controlling Cocaine: Supply Versus Demand Programs. Santa Monica, CA: RAND.
142. Sanchez, T., T. Finlayson, A. Drake, S. Behel, M. Cribbin, E. DiNenno, T. Hall, S. Kramer, and A. Lansky. (2006). Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors-United States, National HIV behavioral surveillance system: Men who have sex with men, November 2003-April 2005. Morbidity and Mortality Weekly Report, 55 (SS06), 1-16.
143. Scott, G., S.D. Thomas, H.A. Pollack, and B. Ray. (2007). Observed patterns of illicit opiate overdose deaths in Chicago, 1999-2003. Journal of Urban Health, 84 (2), 292-306.
144. Substance Abuse and Mental Health Services Administration. (2002). Emergency Department Trends from DAWN: Final Estimates 194-2001. Available: http://dawninfo.samhsa.gov/old_dawn/pubs_94_02/edpubs/2001final/default.asp [accessed August 2010].
145. Substance Abuse and Mental Health Services Administration. (2003). Results from the 2002 National Survey on Drug Use and Health: National Findings. Washington, DC: U.S. Department of Health and Human Services. Available: http://www.samhsa.gov/oas/nhsda/2k2nsduh/Results/2k2Results.htm#1.2 [accessed August 2010].
146. Substance Abuse and Mental Health Services Administration. (2007). Substate Area Estimates of Substance Use Disorders for Maryland, 2005 and 2006. Rockville, MD: U.S. Department of Health and Human Services.
147. Substance Abuse and Mental Health Services Administration. (2008). Results from the 2007 National Survey on Drug Use and Health: National Findings. Available: http://www.oas.samhsa.gov/nsduh/2k7nsduh/2k7Results.pdf [accessed August 2010].
148. Tragler, G., J.P. Caulkins, and G. Feichtinger. (2001). Optimal dynamic allocation of treatment and enforcement in illicit drug control. Operations Research, 49 (3), 352-362.
149. Trunzo, D., and L. Henderson. (2007). Older Adult Admissions to Substance Abuse Treatment: Findings from the Treatment Episode Data Set. Paper presented at the meeting of the American Public Health Association, Washington, DC. Available: http://apha.confex.com/apha/135am/webprogram/Paper160959.html [accessed August 2010].
150. Zarkin, G.A., L.J. Dunlap, J.W. Bray, and W.M. Wechsberg. (2002). The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment. Journal of Substance Abuse Treatment, 23 (4), 261-267.
151. Aos, S., M. Miller, and E. Drake. (2006). Evidence-Based Adult Corrections Programs: What Works and What Does Not. Olympia: Washington State Institute for Public Policy.
152. Baltimore City Health Department. (2006). Drug Treatment in Baltimore: 2005. Available: http://www.baltimorehealth.org/snapshots/DRUG_FINAL_6_6_06.pdf [accessed August 2010].
153. Belenko, S. (1998). Research on drug courts: A critical review. National Drug Court Institute Review, 1, 1-14.
154. Belenko, S. (2000). Research on drug courts: A critical review. National Drug Court Institute Review, 2, 1-58.
155. Belenko, S.R. (2001). Research on Drug Courts: A Critical Review 2001 Update. New York: The National Center on Addiction and Substance Abuse at Columbia University.
156. Bhati, A., J. Roman, and A. Chaifin. (2008). To Treat or Not to Treat: Evidence on the Prospects of Expanding Treatment to Drug-Involved Offenders. Washington, DC: Urban Institute. Available: http://www.urban.org/publications/411645.html [accessed August 2010].
157. Bickel, W.K., L.A. Marsch, A.R. Buchhalter, and G.J. Badger. (2008). Computerized behavior therapy for opioid-dependent outpatients: A randomized controlled trial. Experimental and Clinical Psychopharmacology, 16, 264-274.
158. Booth, R.E., C. Kwiatkowski, M.Y. Iguchi, F. Pinto, and D. John. (1998). Facilitating treatment entry among out-of-treatment injection drug users. Public Health Report, 113 (S1), 116-128.
159. Bureau of Justice Statistics. (2009). Prisoners in 2008. Washington, DC: U.S. Department of Justice. Available: http://bjs.ojp.usdoj.gov/content/pub/pdf/p08.pdf [accessed August 2010].
160. Butler, C.B., and S. Swanton. (2006). The mobile health experience: A blueprint for expanding access to substance abuse treatment. Journal of Maintenance in the Addictions, 3, 17-36.
161. Cacciola, J.S., M.I. Alterman, A.T. McLellan, Y.T. Lin, and K.G. Lynch. (2007). Initial evidence for the reliability and validity of a "lite" version of the Addiction Severity Index. Drug and Alcohol Dependence, 87 , 297-302.
162. Carballo, J.L., J.R. Fernández-Hermida, L.C. Sobell, M. Dum, R. Secades-Villa, O. García-Rodríguez, J.M. Errasti-Pérez, and S. Alhalabí-Diaz. (2008). Differences among substance abusers in Spain who recovered with treatment or on their own. Addictive Behaviors, 33 , 94-105.
163. Carroll, K.M., and L.S. Onken. (2005). Behavioral therapies for drug abuse. American Journal of Psychiatry, 162, 1,452-1,460.
164. Carroll, K.M., S.A. Ball, S. Martino, C. Nich, T.A. Babuscio, K.F. Nuro, M.A. Gordon, G.A. Portnoy, and B.J. Rounsaville. (2008). Computer-assisted delivery of cognitivebehavioral therapy for addiction: A randomized trial of CBT4CBT. American Journal of Psychiatry, 165, 881-888.
165. Caulkins, J.P., S.S. Everingham, C.P. Rydell, J. Chiesa, and S. Bushway. (1999). An Ounce of Prevention, a Pound of Uncertainty: The Cost-Effectiveness of School-Based Drug Prevention Programs. Santa Monica, CA: RAND.
166. Chandler, R.K., B.W. Fletcher, and N.D. Volkow. (2009). Treating drug abuse and addiction in the criminal justice system. Journal of the American Medical Association, 301, 183-190.
167. Cornish, J.W., G.E. Woody, D. Wilson, A.T. McLellan, B. Vandergrift, and C.P. O'Brien. (1997). Naltrexone pharmacotherapy for opioid dependent federal probationers. Journal of Substance Abuse Treatment, 14 , 529-534.
168. Daley, M., C.T. Love, D.S. Shepard, C.B. Petersen, K.L. White, and F.B. Hall. (2004). Costeffectiveness of Connecticut's in-prison substance abuse treatment. Journal of Offender Rehabilitation, 39 , 69-92.
169. Dawson, D.A., B.F. Grant, F.S. Stinson, P.S. Chou, B. Huang, and W.J. Ruan. (2005). Recovery from DSM-IV alcohol dependence: United States, 2001-2002. Addiction, 100, 281-292.
170. DeFulio, A., W.D. Donlin, C.J. Wong, and K. Silverman. (2009). Employment-based abstinence reinforcement as a maintenance intervention for the treatment of cocaine dependence: A randomized controlled trial. Addiction, 104, 1,530-1,538.
171. Dennis, M., C.K. Scott, and R. Funk. (2003). An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders. Evaluation and Program Planning, 26, 339-352.
172. Dennis, M., C.K. Scott, R. Funk, and M.A. Foss. (2005). The duration and correlates of addiction and treatment careers. Journal of Substance Abuse Treatment, 28 , S51-S62.
173. Dennis, M.L., M.A. Foss, and C.K. Scott. (2007). An eight-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Evaluation Review, 31 , 585-612.
174. Ettner, S.L., D. Huang, E. Evans, D.R. Ash, M. Hardy, M. Jourabchi, and Y.I. Hser. (2006). Benefit-cost in the California treatment outcome project: Does substance abuse treatment "pay for itself"? Health Services Research, 41 , 192-213.
175. Faggiano, F., F.D. Vigna-Taglianti, E. Versino, A. Zambon, A. Borraccino, P. Lemma. (2005). School-based prevention for illicit drugs' use. Cochrane Database of Systematic Reviews 18 (2). Available: http://www2.cochrane.org/reviews/en/ab003020.html [accessed August 2010].
176. Glaze, L.E., and T.P. Bonczar. (2006). Probation and Parole in the United States, 2005. NCJ#215091. Washington DC: U.S. Department of Justice, Office of Justice Programs.
177. Godfrey, C., D. Stewart, and M. Gossop. (2004). Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction, 99 , 697-707.
178. Gordon, M.S., T.W. Kinlock, R.P. Schwartz, and K.E. O'Grady. (2008). A randomized clinical trial of methadone maintenance for prisoners: Findings at 6-months' post-release. Addiction, 103, 1,333-1,342.
179. Gossop, M., J. Marsden, D. Stewart, and T. Kidd. (2003). The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction, 98 , 291-303.
180. Greenfield, L., J.V. Brady, K.J. Bestman, and A. De Smet. (1996). Patient retention in mobile and fixed-site methadone maintenance treatment. Drug and Alcohol Dependence, 42 , 125-131.
181. Grella, C.E., L. Greenwell, M. Prendergast, D. Farabee, E. Hall, J. Cartier, and W. Burdon. (2007). Organizational characteristics of drug abuse treatment programs for offenders. Journal of Substance Abuse Treatment, 32 , 291-300.
182. Higgins, S.T., G.J. Badger, and A.J. Budney. (2000). Initial abstinence and success in achieving longer term cocaine abstinence. Experimental and Clinical Psychopharmacology, 8, 377-386.
183. Hser, Y., V. Hoffman, C.E. Grella, and M.D. Anglin. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58 (5), 503-508.
184. Hser, Y.I., M.E. Stark, A. Paredes, D. Huang, M.D. Anglin, and R. Rawson. (2006). A 12-year follow-up of a treated cocaine-dependent sample. Journal of Substance Abuse Treatment, 30(3), 219-226.
185. Hser, Y.I., D. Longshore, and M.D. Anglin. (2007a). The life course perspective on drug use: A conceptual framework for understanding drug use trajectories. Evaluation Review, 31 , 515-547.
186. Hser, Y.I., D. Huang, C.P. Chou, and M.D. Anglin. (2007b). Trajectories of heroin addiction: Growth mixture modeling results based on a 33-year follow-up study. Evaluation Review, 31 , 548-563.
187. Hubbard, R.L., M.E. Marsden, J.V. Rachal, H.J. Harwood, E.R. Cavanaugh, and H.M. Ginzberg. (1989). Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill: University of North Carolina Press.
188. Hubbard, R.L., S.G. Craddock, P.M. Flynn, J. Anderson, and R.M. Etheridge. (1997). Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors, 11 (4), 261-278.
189. Hulse, G.K., N. Morris, D. Arnold-Reed, and R.J. Tait. (2009). Improving clinical outcomes in treating heroin dependence: Randomized, controlled trial of oral or implant naltrexone. Archives of General Psychiatry, 66, 1,108-1,115.
190. Kinlock, T.W., M.S. Gordon, R.P. Schwartz, and K.E. O'Grady. (2008). A study of methadone maintenance for male prisoners: 3-month post-release outcomes. Criminal Justice and Behavior, 35 , 34-47.
191. Laudet, A.B., and W. White. (2010). What are your priorities? Identifying service needs across recovery stages to inform service development. Journal of Substance Abuse Treatment, 38 , 51-59.
192. Marsch, L.A., W.K. Bickel, and M.J. Grabinski. (2007). Application of interactive, computer technology to adolescent substance abuse prevention and treatment. Adolescent Medicine State of the Art Review, 18 , 342-356.
193. McAuliffe, W.E., M. Hsu, E. Artigiani, and E.D. Wish. (2008). Need for Substance Abuse Treatment in Maryland: Final Report. Supported by a grant from the Maryland Department of Health and Mental Hygiene and the Alcohol and Drug Abuse Administration to the Center for Substance Abuse Research at the University of Maryland, College Park. Available: http://maryland-adaa.org/content_documents/NeedAssessmentFINAL.pdf [accessed August 2010].
194. McCarty, D., Y. Caspi, L. Panas, M. Krakow, and D.H. Mulligan. (2000 Detoxification centers: Who's in the revolving door? Journal of Behavioral Health Services and Research, 27 (3), 245-256.
195. McCollister, K.E., M.T. French, M.L. Prendergast, E. Hall, and S. Sacks. (2004). Long-term cost-effectiveness of addiction treatment for criminal offenders. Justice Quarterly, 21 , 659-679.
196. McKay, J.R. (2005). Is there a case for extended interventions for alcohol and drug use disorders? Addiction, 100, 1,594-1,610.
197. McLellan, A.T., and K. Meyers. (2004). Contemporary addiction treatment: A review of systems problems for adults and adolescents. Biological Psychiatry, 56, 764-770.
198. McLellan, A.T., H. Kushner, D. Metzger, R. Peters, I. Smith, G. Grissom, H. Pettinati, and M. Argeriou. (1992). The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9, 199-213.
199. McLellan, A.T., G.R. Grissom, D. Zanis, M. Randall, P. Brill, and C.P. O'Brien. (1997). Problem-service "matching" in addiction treatment: A prospective study in 4 programs. Archives of General Psychiatry, 54 , 730-735.
200. McLellan, A.T., T.A. Hagan, M. Levine, K. Meyers, F. Gould, M. Bencivengo, J. Durell, and J. Jaffe. (1999). Does clinical case management improve outpatient addiction treatment? Drug and Alcohol Dependence, 55 , 91-103.
201. McLellan, A.T., D. Carise, and H.D. Kleber. (2003). Can the national addiction treatment infrastructure support the public's demand for quality care? Journal of Substance Abuse Treatment, 25 , 117-121.
202. McLellan, A.T., R.L. Weinstein, Q. Shen, C. Kendig, and M. Levine. (2005a). Improving continuity of care in a public addiction treatment system with clinical case management. American Journal on Addictions, 14 , 426-440.
203. McLellan, A.T., J.R. McKay, R. Forman, J. Cacciola, and J. Kemp. (2005b). Reconsidering the evaluation of addiction treatment: From retrospective follow-up to concurrent recovery monitoring. Addiction, 100, 447-458.
204. McLellan, A.T., J. Kemp, A. Brooks, and D. Carise. (2008). Improving public addiction treatment through performance contracting: The Delaware experiment. Health Policy, 87 (3), 296-308.
205. Meara, E., and R. Frank. (2005). Spending on substance abuse: How much is enough? Addiction, 100, 1,240-1,248.
206. Mitchell, O., D.B. Wilson, and D.L. MacKenzie. (2007). Does incarceration-based drug treatment reduce recidivism? A meta-analytic synthesis of the research. Journal of Experimental Criminology, 3, 353-375.
207. Moos, R.H., and B.S. Moos. (2007). Treated and untreated alcohol-use disorders. Course and predictors of remission and relapse. Evaluation Review, 31 , 564-584.
208. Mumola, C.J. (1999). Substance Abuse and Treatment, State and Federal Prisoners. NCJ #172871. Washington, DC: Bureau of Justice Statistics.
209. Mumola, C.J., and J.C. Karberg. (2006). Drug Use and Dependence, State and Federal Prisoners, 2004. NCJ #213530. Washington, DC: Bureau of Justice Statistics.
210. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. (1998). Effective medical treatment of opiate addiction. Journal of the American Medical Association, 280 1,936-1,943.
211. National Research Council. (2001). Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us. Committee on Data and Research for Policy on Illegal Drugs. C.F. Manski, J.V. Pepper, and C.V. Petrie (Eds.). Committee on Law and Justice and Committee on National Statistics, Commission on Behavioral and Social Sciences and Education. Washington, DC: National Academy Press.
212. Nurco, D.N., J.C. Ball, J.W. Shaffer, and T.E. Hanlon. (1985). The criminality of narcotic addicts. Journal of Nervous and Mental Disease, 173 , 94-102.
213. Office of National Drug Control Policy. (2001). What America's Users Spend on Illicit Drugs, 1988-2000. Prepared by Abt Associates. Available: http://www.ncjrs.gov/ondcppubs/publications/pdf/american_users_spend_2002.pdf [accessed August 2010].
214. Olmstead, T.A., J.A. Johnson, P.M. Roman, and J.L. Sindelar. (2005). What are the correlates of substance abuse treatment counselor salaries? Journal of Substance Abuse Treatment, 29 , 181-189.
215. Parthasarathy, S., J. Mertens, C. Moore, and C. Weisner. (2003). Utilization and cost impact of integrating substance abuse treatment and primary care. Medical Care, 41 , 357-367.
216. Patapis, N.S., and B.R. Nordstrom. (2006). Research on naltrexone in the criminal justice system. Journal of Substance Abuse Treatment, 31 , 113-115.
217. Pelissier, B., N. Jones, and T. Cadigan. (2007). Drug treatment aftercare in the criminal justice system: A systematic review. Journal of Substance Abuse Treatment, 32 , 311-320.
218. Perron, B.E., and C.L. Bright. (2008). The influence of legal coercion on dropout from substance abuse treatment: Results from a national survey. Drug and Alcohol Dependence, 92 , 123-131.
219. Reuter, P., and H. Pollack. (2006). How much can treatment reduce national drug problems? Addiction, 101, 341-347.
220. Scott, C.K., and M.L. Dennis. (2009). Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users. Addiction, 104, 959-971.
221. Scott, C.K., M.A. Foss, and M.L. Dennis. (2003). Factors influencing initial and longer-term responses to substance abuse treatment: A path analysis. Evaluation and Program Planning, 26, 287-296.
222. Scott, C.K., M.A. Foss, and M.L. Dennis. (2005a). Pathways in the relapse-treatment-recovery cycle over 3-years. Journal of Substance Abuse Treatment, 28 , S63-S72.
223. Scott, C.K., M.L. Dennis, and M.A. Foss. (2005b). Utilizing recovery management checkups to shorten the cycle of relapse, treatment reentry and recovery. Drug and Alcohol Dependence, 78 , 325-338.
224. Sells, S.B., and D.D. Simpson. (1980). The case for drug abuse treatment effectiveness based on the DARP research program. British Journal of Addiction, 75 , 117-131.
225. Silverman, K., D. Svikis, C.J. Wong, J. Hampton, M.L. Stitzer, and G.E. Bigelow. (2002). A reinforcement-based therapeutic workplace for the treatment of drug abuse: Three-year abstinence outcomes. Experimental Clinical Psychopharmacology, 10, 228-240.
226. Silverman, K., C.J. Wong, M. Needham, K.N. Diemer, T. Knealing, D. Crone-Todd, M. Fingerhood, P. Nuzzo, and K. Kolodner. (2007). A randomized trial of employmentbased reinforcement of cocaine abstinence in injection drug users. Journal of Applied Behavior Analysis, 40, 387-410.
227. Simpson, D.D., L.J. Savage, and M.R. Lloyd. (1979). Follow-up evaluation of treatment of drug abuse during 1969 to 1972. Archives of General Psychiatry, 36, 772-780.
228. Sindelar, J., and D. Fiellin. (2001). Innovations in treatment for drug abuse: Solutions to a public health problem. Annual Review of Public Health, 22 , 249-272.
229. Sindelar, J.D., and B. Kilmer. (2007). Would More Treatment Reduce Use of Illicit Drugs and the Associated Social Harms? Presented at the Committee on Law and Justice Workshop on Understanding and Controlling the Demand for Illegal Drugs. October, Irvine, CA.
230. Sobell, L.C., J.A. Cunningham, and M.B. Sobell. (1996). Recovery from alcohol problems with and without treatment: Prevalence in two population surveys. American Journal of Public Health, 86, 966-972.
231. Stitzer, M.L., and N.M. Petry. (2006). Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology, 2, 17.1-17.24.
232. Strain, E.C., and M.L. Stitzer. (2006). The Treatment of Opioid Dependence. Baltimore, MD: Johns Hopkins University Press.
233. Strathdee, S.A., E.P. Ricketts, S. Huettner, L. Cornelius, D. Bishai, J.R. Havens, P. Beilenson, P.C. Rapp, J.J. Lloyd, and C.A. Latkin. (2006). Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug Alcohol Dependence, 83 , 225-232.
234. Substance Abuse and Mental Health Services Administration. (1998). Services Research Outcomes Study, 1995-196. ICPSR study 2691. Rockville, MD: U.S. Department of Health and Human Services.
235. Substance Abuse and Mental Health Services Administration. (2007). Substate Area Estimates of Substance Use Disorders for Maryland, 2005 and 2006. Rockville, MD: U.S. Department of Health and Human Services.
236. Substance Abuse and Mental Health Services Administration. (2008). National Survey of Drug Abuse Treatment Services. Available: http://wwwdasis.samhsa.gov/dasis2/nssats.htm [accessed August 2010].
237. Sullivan, L.E., and D.A. Fiellin. (2008). Narrative review: Buprenorphine for opioid-dependent patients in office practice. Annals of Internal Medicine, 148 , 662-670.
238. Taxman, F.S., M.L. Perdoni, and L.D. Harrison. (2007). Drug treatment services for adult offenders: The state of the state. Journal of Substance Abuse Treatment, 32 (3), 239-254.
239. Teesson, M., J. Ross, S. Darke, M. Lynskey, A. R. Ali, A. Ritter, and R. Cooke. (2004). Twelve-Month Outcomes of the Treatment of Heroin Dependence: Findings from the Australian Treatment Outcome Study (ATOS). National Drug and Alcohol Research Centre, Technical report #196. Available: http://notes.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_3/$file/TR.196.pdf [accessed August 2010].
240. Umbricht-Schneiter, A., D.H. Ginn, K.M. Pabst, and G.E. Bigelow. (1994). Providing medical care to methadone clinic patients: Referral vs. on-site care. American Journal of Public Health, 84 , 207-210.
241. U.S. Department of Justice. (1995). The Drug Court Movement. Washington, DC: Office of Justice Programs.
242. U.S. Department of Justice. (1998). Looking at a Decade of Drug Courts. Washington, DC: Office of Justice Programs.
243. U.S. Department of Justice. (2006). Drug Courts: The Second Decade. Washington, DC: Office of Justice Programs.
244. U.S. Government Accountability Office. (2005). Adult Drug Courts: Evidence Indicates Recidivism Reductions and Mixed Results for Other Outcomes. Publication #GAO 05-219. Report to Congressional Committees. Washington, DC: U.S. Government Accountability Office.
245. Vaillant, G.E. (1973). A 20-year follow-up of New York narcotic addicts. Archives of General Psychiatry, 29 (2), 237-241.
246. Weisner, C., G.T. Ray, J.R. Mertens, D.D. Satre, and C. Moore. (2003a). Short-term alcohol and drug treatment outcomes predict long-term outcome. Drug and Alcohol Dependence, 10, 281-294.
247. Weisner, C., H. Matzger, and L.A. Kaskutas. (2003b). How important is treatment? Oneyear outcomes of treatment and untreated alcohol-dependent individuals. Addiction, 98 , 901-911.
248. Boyd, C.J., and S.E. McCabe. (2008). Coming to terms with the nonmedical use of prescription medications. Substance Abuse Treatment, Prevention, and Policy, 3.
249. Caulkins, J.P. (2001). Drug prices and emergency department mentions of cocaine and heroin. American Journal Public Health, 91 (9), 1,446-1,448.
250. Caulkins, J.P., and S. Chandler. (2006). Long-run trends in incarceration of drug offenders in the U.S. Crime and Delinquency, 52 (4), 619-641.
251. Dave, D. (2006). The effects of cocaine and heroin price on drug-related emergency department visits. Journal of Health Economics, 25 (2), 311-333.
252. Galea, S., and M. Tracy. (2007). Participation rates in epidemiologic studies. Annals of Epidemiology, 17 (9), 649-653.
253. Grucza, R.A., A.M. Abbacchi, T.R. Przybeck, and J.C. Gfroerer. (2007). Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction, 102(4), 623-629.
254. Laub, J., and R. Sampson. (2003). Shared Beginnings, Divergent Lives: Delinquent Boys to Age 70. Cambridge, MA: Harvard University Press.
255. Johnson, L.D., P.M. O'Malley, J.E. Schulenberg, and J.G. Bachman. (2006). The Aims and Objectives of the Monitoring the Future Study and Progress Toward Fulfilling Them as of 2006.Monitoring the Future Occasional Paper Series. Available: http://monitoringthefuture.org/pubs/occpapers/occ65.pdf [accessed July 2010].
256. Moffitt, T.E., A. Caspi, A. Taylor, J. Kokaua, B.J. Milne, G. Polanczyk, and R. Poulton. (2010). How common are common mental disorders? Evidence that lifetime rates are doubled by prospective versus retrospective ascertainment. Psychological Medicine, 40(6), 899-909.
257. National Research Council. (2001). Informing America's Policy on Illegal Drugs: What We Don't Know Keeps Hurting Us. Committee on Data and Research for Policy on Illegal Drugs. C.F. Manski, J.V. Pepper, and C.V. Petrie (Eds.). Committee on Law and Justice and Committee on National Statistics, Commission on Behavioral and Social Sciences and Education. Washington, DC: National Academy Press.
258. Office of National Drug Control Policy. (2001). What America's Users Spend on Illegal Drugs, 1988-2000. Washington, DC: The Executive Office of the President.